Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Data on Tardive Dyskinesia Improvement and Stability of Psychiatric Symptoms at American Psychiatric Association Annual Meeting 2022 - PR Newswire
Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 12:30
